ipharmaservicesJun 27UCB’s Epilepsy Drug Briviact (brivaracetam) Gains Approval in Japan for Focal Onset Seizures | 2024 | iPharmaCenter
ipharmaservicesJun 24Takeda Announces Approval of Livtencity in Japan for Resistant Post-Transplant Cytomegalovirus (CMV) Infection/Disease
ipharmaservicesFeb 17Japan Drug Approvals | 日本の医薬品承認 | ニュース | 日本のニュース速報 | 健康管理 | 2024 | iPharmaCenter
ipharmaservicesMar 12, 2021Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System
ipharmaservicesAug 25, 2020Merck’s Keytruda received one more indication and dosage form approval in Japan
ipharmaservicesJun 3, 2020Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
